In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abaxis Inc.

www.abaxis.com

Latest From Abaxis Inc.

Medtech Business Models: All Razor And No Blades – Is “Big Iron” Back In Vogue?

The conventional wisdom in the medtech industry is to pursue the “razor-razor blade” business model, as each placement of capital equipment generates a lucrative annuity of recurring revenues from disposables. The corollary to this conventional wisdom is that so-called “big iron” is to be avoided as, in sharp contrast, it suffers from greater early cash requirements and longer sales cycles that create difficulties forecasting quarterly revenues, and provides no annuities. But that view is no longer the only one that counts, Health Advances CEO Mark Speers argues.

Market Intelligence Business Strategies

CLIA Waiver Wave? Applications Up In FY 2014 After A Prior-Year Lull

The volume of applications for diagnostic test waivers under the Clinical Laboratory Improvement Amendments increased fivefold in FY 2014, but the total numbers are small, and the change may simply reflect routine year-to-year variation.

Medical Device Regulation

Execs On The Move, December 2014

Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.

Medical Device BioPharmaceutical

Labs Should Contact Manufacturers For Ebola Decontamination Guidance – CDC

Questions on how to decontaminate laboratory analyzers are coming into the Centers for Disease Control and Prevention as U.S. laboratories prepare to accept suspected Ebola specimens, an official says.

Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Abaxis Inc.
  • Senior Management
  • Clinton H Severson, Chmn., Pres. & CEO
    Alberto R Santa Ines, VP, Fin. & CFO
    Kenneth P Aron, PhD, CTO
    Ross Taylor, VP, Bus. Dev. & Investor Relations
  • Contact Info
  • Abaxis Inc.
    Phone: (510) 675-6500
    3240 Whipple Rd.
    Union City, CA 94587
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register